Drug intelligence / Profile preview

Gynofar

Development stage: Unknown
Lead developer: Pharmedic
Modality: Small Molecules
Administration: Topical

Overview

**Gynofar** is a Pharmedic external-use topical antiseptic and feminine-hygiene drug brand. The standard medicinal Gynofar 250 and Gynofar 500 solutions contain copper sulfate 0.250 g per 100 mL; Gynofar Gel contains copper sulfate 0.250 g per 100 g. Pharmedic lists these products for vulvar pruritus, vaginitis, leucorrhea, and external cleansing or antisepsis of wounds, furuncles, and prickly heat. ([pharmedic.com.vn](https://www.pharmedic.com.vn/en/gynofar-250.html))

Brand names: Gynofar

Beyond the preview

Go deeper on Gynofar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gynofar.

Explore the full profile